Clinical Trial Update: A Study of BGM0504 in Participants With Obesity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BGM0504 for obesity is currently recruiting, with no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• BGM0504

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Obesity | Phase 2 | Status: RECRUITING